These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1896777)

  • 1. Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus.
    Elkassaby MH
    Trop Med Parasitol; 1991 Jun; 42(2):79-81. PubMed ID: 1896777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus.
    Baraka OZ; Mahmoud BM; Marschke CK; Geary TG; Homeida MM; Williams JF
    Eur J Clin Pharmacol; 1996; 50(5):407-10. PubMed ID: 8839664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The entry of ivermectin and suramin into Onchocerca ochengi nodules.
    Cross HF; Bronsvoort BM; Wahl G; Renz A; Achu-Kwi D; Trees AJ
    Ann Trop Med Parasitol; 1997 Jun; 91(4):393-401. PubMed ID: 9290846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
    Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
    Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
    Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G
    Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
    Awadzi K; Opoku NO; Addy ET; Quartey BT
    Trop Med Parasitol; 1995 Jun; 46(2):131-7. PubMed ID: 8525285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin in the treatment of onchocerciasis in Britain.
    Godfrey-Faussett P; Dow C; Black ME; Bryceson AD
    Trop Med Parasitol; 1991 Jun; 42(2):82-4. PubMed ID: 1896778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin.
    Chavasse DC; Post RJ; Davies JB; Whitworth JA
    Trop Med Parasitol; 1993 Sep; 44(3):155-8. PubMed ID: 8256088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin.
    Cooper PJ; Awadzi K; Ottesen EA; Remick D; Nutman TB
    J Infect Dis; 1999 Mar; 179(3):738-42. PubMed ID: 9952390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How long do the effects of ivermectin on adult Onchocerca volvulus persist?
    Kläger S; Whitworth JA; Post RJ; Chavasse DC; Downham MD
    Trop Med Parasitol; 1993 Dec; 44(4):305-10. PubMed ID: 8134772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
    Fischer P; Kipp W; Kabwa P; Buttner DW
    Am J Trop Med Hyg; 1995 Aug; 53(2):171-8. PubMed ID: 7677220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico].
    Rodríguez-Pérez MA; Reyes-Villanueva F
    Salud Publica Mex; 1994; 36(3):281-90. PubMed ID: 7940009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of ivermectin in the treatment of human onchocerciasis.
    Taylor HR; Greene BM
    Am J Trop Med Hyg; 1989 Oct; 41(4):460-6. PubMed ID: 2679172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onchocerciasis-associated morbidity: hypothesis.
    Mawson AR; WaKabongo M
    Trans R Soc Trop Med Hyg; 2002; 96(5):541-2. PubMed ID: 12474485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of chloroquine by Onchocerca volvulus in vivo and in vitro.
    Mahmoud BM; Vandewaa EA; Geary TG; Guderian R; Williams JF
    Ann Trop Med Parasitol; 1991 Oct; 85(5):523-8. PubMed ID: 1809245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
    Tan B; Opoku N; Attah SK; Awadzi K; Kuesel AC; Lazdins-Helds J; Rayner C; Ryg-Cornejo V; Sullivan M; Fleckenstein L
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010005. PubMed ID: 35333880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients.
    Eng JK; Prichard RK
    Mol Biochem Parasitol; 2005 Aug; 142(2):193-202. PubMed ID: 15885823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.
    Gardon J; Boussinesq M; Kamgno J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO
    Lancet; 2002 Jul; 360(9328):203-10. PubMed ID: 12133654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.